(MM) (IDIX)

(MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IDIX

<< Previous 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Next >>

Date	Time	Source	Headline	Symbol	Company
28/09/2007	14:00	PR Newswire (US)	Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs	NASDAQ:IDIX	(MM)
06/09/2007	21:05	PR Newswire (US)	Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences	NASDAQ:IDIX	(MM)
02/08/2007	21:05	PR Newswire (US)	Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results	NASDAQ:IDIX	(MM)
13/07/2007	11:45	PR Newswire (US)	Valopicitabine Development Program Placed on Clinical Hold in the United States	NASDAQ:IDIX	(MM)
18/06/2007	15:06	PR Newswire (US)	Idenix Pharmaceuticals, Inc. Names Ronald C. Renaud Jr. as Chief Financial Officer	NASDAQ:IDIX	(MM)
12/06/2007	13:00	PR Newswire (US)	Valopicitabine Combined with Standard of Care Cleared Hepatitis C Virus in 72% of Patients Who Completed 12 Weeks of Treatment i	NASDAQ:IDIX	(MM)
29/05/2007	14:30	PR Newswire (US)	Idenix Pharmaceuticals To Present at the Bear Stearns Biotech Confab and the Goldman Sachs 28th Annual Global Healthcare Confere	NASDAQ:IDIX	(MM)
15/05/2007	14:30	PR Newswire (US)	Idenix Pharmaceuticals to Present at Citi's 2007 Healthcare Conference	NASDAQ:IDIX	(MM)
30/04/2007	08:00	PR Newswire (US)	Sebivo(R) (Telbivudine) Approved in European Union as a New Treatment for Chronic Hepatitis B Patients	NASDAQ:IDIX	(MM)
26/04/2007	22:05	PR Newswire (US)	Idenix Pharmaceuticals Reports First Quarter Financial Results	NASDAQ:IDIX	(MM)
23/04/2007	22:05	PR Newswire (US)	Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences	NASDAQ:IDIX	(MM)
18/04/2007	22:05	PR Newswire (US)	Idenix Announces Data Presentations at the 2007 Digestive Disease Week Meeting	NASDAQ:IDIX	(MM)
17/04/2007	22:38	PR Newswire (US)	Idenix to Host Conference Call Discussing First Quarter 2007 Financial Results	NASDAQ:IDIX	(MM)
12/04/2007	13:55	PR Newswire (US)	Idenix Reports Results from Two Phase IIb Studies of the Combination of Valopicitabine and Pegylated Interferon in Hepatitis C G	NASDAQ:IDIX	(MM)
20/03/2007	21:05	PR Newswire (US)	Idenix Pharmaceuticals, Inc. Announces Resignation of Chief Financial Officer	NASDAQ:IDIX	(MM)
06/03/2007	21:05	PR Newswire (US)	Idenix Pharmaceuticals to Present at the Cowen & Company 27th Annual Healthcare Conference	NASDAQ:IDIX	(MM)
02/03/2007	12:30	PR Newswire (US)	Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results	NASDAQ:IDIX	(MM)
02/03/2007	12:00	PR Newswire (US)	SEBIVO(R) (Telbivudine) Approved in China as New Treatment Option for Patients with Chronic Hepatitis B	NASDAQ:IDIX	(MM)
01/03/2007	21:05	PR Newswire (US)	Preclinical Data From Two Novel Idenix Compounds for the Treatment of HIV Presented at Conference on Retroviruses and Opportunis	NASDAQ:IDIX	(MM)
01/03/2007	16:00	PR Newswire (US)	Idenix Announces Thirteen Data Presentations at the 2007 European Association For the Study of the Liver	NASDAQ:IDIX	(MM)
23/02/2007	12:45	PR Newswire (US)	SEBIVO(R) (telbivudine) Recommended for Approval in European Union as a new Treatment for Patients with Chronic Hepatitis B	NASDAQ:IDIX	(MM)
20/02/2007	13:30	PR Newswire (US)	Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference	NASDAQ:IDIX	(MM)
16/02/2007	13:30	PR Newswire (US)	Idenix to Host Conference Call Discussing Fourth Quarter and Year-End 2006 Financial Results	NASDAQ:IDIX	(MM)
16/02/2007	13:30	PR Newswire (US)	Idenix to Host Conference Call Discussing Fourth Quarter and Year-End 2006 Financial Results	NASDAQ:IDIX	(MM)
31/01/2007	13:30	PR Newswire (US)	Idenix Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference	NASDAQ:IDIX	(MM)
31/01/2007	13:30	PR Newswire (US)	Idenix Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference	NASDAQ:IDIX	(MM)
08/01/2007	22:00	PR Newswire (US)	Idenix Pharmaceuticals, Inc. Announces Appointment of Douglas Mayers, M.D. as Executive Vice President and Chief Medical Officer	NASDAQ:IDIX	(MM)
03/01/2007	13:45	PR Newswire (US)	Idenix Pharmaceuticals To Present at the JP Morgan 25th Annual Healthcare Conference	NASDAQ:IDIX	(MM)
07/12/2006	13:30	PR Newswire (US)	Norman C. Payson, M.D., Elected to Board of Directors of Idenix Pharmaceuticals	NASDAQ:IDIX	(MM)
07/12/2006	13:30	PR Newswire (US)	Norman C. Payson, M.D., Elected to Board of Directors of Idenix Pharmaceuticals	NASDAQ:IDIX	(MM)